FALLS CHURCH, Va., Nov. 01, 2018 /PRNewswire-PRWeb/ -- Come to Princeton
What should clinical research industry stakeholders keep in mind when implementing and managing risk-based quality management programs?
How is the FDA using data to quantify risk to determine where to conduct site inspections?
The Clinical Trial Risk and Performance Management Summit and Dr. Jean Mulinde, Senior Advisor, Division of Clinical Compliance Evaluation, CDER, FDA have the answers.
Come to Princeton Nov. 14 and 15 for the first-ever Metrics Champion Consortium Summit. This will be an exclusive gathering of the top minds in trial performance metrics, spearheaded by MCC Executive Director Linda Sullivan. The keynote speaker will be Ken Getz, Associate Professor and Director, CSDD, Tufts University and Founder and Board Chair, CISCRP, clinical trials guru, founder of CenterWatch and an MCC partner. Plan on attending this must-see presentation: Next Gen Benchmarking in Biopharma by Linda Martin, President and Founder, The KMR Group.
The roster of experts will guide attendees through the issues that are top of mind in clinical trials metrics today:
The Clinical Trial Risk and Performance Management Summit is interactive. Attendees roll up their sleeves with speakers and fellow attendees as they tackle case studies that will bring clarity to the metrics process — and provide needed answers.
Who Will Benefit:
This event is designed for professionals from pharmaceutical, biotechnology and medical device companies; CROs; and other clinical service providers who have responsibilities in the following areas:
Conference Details Clinical Trial Risk and Performance Management Summit **Presented by Metrics Champion Consortium a Division of CenterWatch ** Nov. 14-15, 2018 – Princeton, NJ http://www.fdanews.com/ctriskperformancemngmntsummit
Tuition: Regular Pricing: $1,797 Significant team discounts are available.
Easy Ways to Register Online: http://www.fdanews.com/ctriskperformancemngmntsummit By phone: 888-838-5578 or 703-538-7600
About MCC Leading the drug-development enterprise in the adoption and utilization of standardized metrics and benchmarks to drive performance improvement. Founded in 2006, MCC is the leading industry association dedicated to the development of standardized performance metrics to improve clinical trials. MCC provides the collaborative environment for biopharmaceutical and device sponsors, service providers and sites to improve clinical-trial development through use of MCC standardized performance metrics.
Clinical Trial Risk and Performance Management Summit **Presented by Metrics Champion Consortium a Division of CenterWatch** Nov. 14-15, 2018 – Princeton, NJ http://www.fdanews.com/ctriskperformancemngmntsummit
Subscribe to our Free Newsletters!